Epidemiological and clinical characteristics of hepatocellular carcinoma in Xiamen

IF 2.4 3区医学 Q3 ONCOLOGY Cancer Epidemiology Pub Date : 2024-10-31 DOI:10.1016/j.canep.2024.102691

Zhenzhen Zhang , Meixia Wang , Yanfang Wu , Guobin Chen , Boheng Zhang

{"title":"Epidemiological and clinical characteristics of hepatocellular carcinoma in Xiamen","authors":"Zhenzhen Zhang , Meixia Wang , Yanfang Wu , Guobin Chen , Boheng Zhang","doi":"10.1016/j.canep.2024.102691","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the epidemiological characteristics of hepatocellular carcinoma in Xiamen and offer recommendations for its control and prevention. Methods: Data obtained from liver cancer screening in 2016–2018 and 2019–2020 in patients with hepatocellular carcinoma in Xiamen were collected using Xiamen Healthcare Big Data Platform. Epidemiological characteristics were analyzed descriptively by different years. Results: From 2016–2020, there were 3740 patients with hepatocellular carcinoma in Xiamen. In the patients, the percentage of males was higher than that of females (83.13 % vs 16.87 %). From 2019–2020, there was an increase in the detection rates for disorders including hepatitis B, hypertension, diabetes, fatty liver and cirrhosis of the liver, and there was a decrease in the prevalence of hepatitis C. There was an increase in the values of all hematological indicators of infection in patients with liver cancer in 2019–2020 compared with the previous three years. From 2016–2020, there was a year-on-year increase in the prevalence of liver cancer and fatty liver. From 2018–2020, there was an increasing trend in the prevalence of liver cancer in overweight patients in the population with fatty liver. Conclusion: In 2019–2020, there was an increase in the prevalence of chronic diseases in patients with hepatocellular carcinoma. Comprehensive liver cancer screening provides an important guide for the prevention, early diagnosis and treatment of liver cancer and for clinicians to assess patients’ condition.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"93 ","pages":"Article 102691"},"PeriodicalIF":2.4000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S187778212400170X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective

To investigate the epidemiological characteristics of hepatocellular carcinoma in Xiamen and offer recommendations for its control and prevention. Methods: Data obtained from liver cancer screening in 2016–2018 and 2019–2020 in patients with hepatocellular carcinoma in Xiamen were collected using Xiamen Healthcare Big Data Platform. Epidemiological characteristics were analyzed descriptively by different years. Results: From 2016–2020, there were 3740 patients with hepatocellular carcinoma in Xiamen. In the patients, the percentage of males was higher than that of females (83.13 % vs 16.87 %). From 2019–2020, there was an increase in the detection rates for disorders including hepatitis B, hypertension, diabetes, fatty liver and cirrhosis of the liver, and there was a decrease in the prevalence of hepatitis C. There was an increase in the values of all hematological indicators of infection in patients with liver cancer in 2019–2020 compared with the previous three years. From 2016–2020, there was a year-on-year increase in the prevalence of liver cancer and fatty liver. From 2018–2020, there was an increasing trend in the prevalence of liver cancer in overweight patients in the population with fatty liver. Conclusion: In 2019–2020, there was an increase in the prevalence of chronic diseases in patients with hepatocellular carcinoma. Comprehensive liver cancer screening provides an important guide for the prevention, early diagnosis and treatment of liver cancer and for clinicians to assess patients’ condition.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

厦门肝细胞癌的流行病学和临床特征

目的调查厦门地区肝细胞癌的流行病学特征，并为其控制和预防提供建议。方法：利用厦门市健康医疗大数据平台，收集2016-2018年和2019-2020年厦门市肝癌患者的肝癌筛查数据。按不同年份对流行病学特征进行描述性分析。结果显示2016-2020年，厦门市共有3740名肝细胞癌患者。患者中，男性比例高于女性（83.13% vs 16.87%）。2019-2020年，乙肝、高血压、糖尿病、脂肪肝、肝硬化等疾病检出率有所上升，丙肝患病率有所下降，2019-2020年肝癌患者各项血液学感染指标值较前三年有所上升。2016-2020 年，肝癌和脂肪肝的患病率逐年上升。2018-2020年，脂肪肝人群中超重患者的肝癌患病率呈上升趋势。结论2019-2020年，肝癌患者中慢性病患病率呈上升趋势。肝癌综合筛查为肝癌的预防、早期诊断和治疗以及临床医生评估患者病情提供了重要指导。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Cancer Epidemiology 医学-肿瘤学

CiteScore

4.50

自引率

3.80%

发文量

200

审稿时长

39 days

期刊介绍： Cancer Epidemiology is dedicated to increasing understanding about cancer causes, prevention and control. The scope of the journal embraces all aspects of cancer epidemiology including: • Descriptive epidemiology • Studies of risk factors for disease initiation, development and prognosis • Screening and early detection • Prevention and control • Methodological issues The journal publishes original research articles (full length and short reports), systematic reviews and meta-analyses, editorials, commentaries and letters to the editor commenting on previously published research.